Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Eur J Paediatr Neurol. 2018 Feb 11;22(3):358–368. doi: 10.1016/j.ejpn.2018.02.001

Table 2. tDCS-Related MAE.

Active+CIMT (n=10) Sham+CIMT (n=10)

Reported MAE Proportion of group with MAE reports Total reports (n) Proportion of group with MAE reports Total reports (n) Relative Risk p-value* 95% CI
Headache 0.4 9 0.1 1 4.0 0.303 0.61, 104.2
Unusual feelings on the skin of the head 0.2 5 0.1 1 2.0 >0.999 0.19, 54.0
Itchiness 0.1 5 0.3 6 0.33 0.582 0.01, 2.86
Unusual feelings or emotions 0.1 2 0 0 -- >0.999 0.07, Inf
Dizziness 0 0 0.3 3 -- 0.211 0, 1.28
Nausea 0 0 0.1 1 -- >0.999 0, 14.0
Tingling 0.2 10 0.2 2 1.0 >0.999 0.07, 14.2
Difficulty paying attention 0 0 0.1 1 -- >0.999 0, 14.0

CIMT: Constraint-induced movement therapy; Inf: Infinity; MAE: Minor adverse events; CI: Confidence Interval.

*

Fisher exact test for the proportion of children reporting MAE between groups. Total reports represents the cumulative number of MAEs for the 10 day intervention